Inflammatory gene variants and the risk of biliary tract cancers and stones: A population-based study in China

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Castro, Felipe A ^a   Koshiol, Jill ^a   Hsing, Ann W ^a   Gao, Yu Tang ^b   Rashid, Asif ^c   Chu, Lisa W ^a   Shen, Ming Chang ^d   Wang, Bing Shen ^e   Han, Tian Qua ^f   Zhang, Bai He ^g   Niwa, Shelley ^h   Yu, Kai ^a   Zhang, Hong ⁱ   Chanock, Stephen ^a   Andreotti, Gabriella ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Shanghai Tumor Hospital   (China)

^e FUDAN UNIVERSITY   (China)

^f SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^g SECOND MILITARY MEDICAL UNIVERSITY   (China)

^h WESTAT   (United States)

ⁱ FUDAN UNIVERSITY   (China)

Author keywords

Biliary stones; Biliary tract cancer; Genetic susceptibility; Inflammation

Indexed keywords

I KAPPA B; INTERLEUKIN 8; RIBONUCLEASE L; TUMOR NECROSIS FACTOR; VASCULOTROPIN A;

ARTICLE; BILE DUCT STONE; BILIARY TRACT CANCER; CANCER RISK; CHINA; CONTROLLED STUDY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; GALLBLADDER CANCER; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IL8 GENE; INFLAMMATION; MAJOR CLINICAL STUDY; NFBIL GENE; POPULATION RESEARCH; RNASEL GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TNF GENE; TUMOR GENE; VATER PAPILLA CARCINOMA; VEGFA GENE;

AGED; BILIARY TRACT NEOPLASMS; CASE-CONTROL STUDIES; CHINA; ENDORIBONUCLEASES; FEMALE; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867236883     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-468     Document Type: Article

References (28)

1. Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, La Vecchia C. Epidemiology of biliary tract cancers: an update. Ann Oncol 2009, 20(1):146-159.
2. Hsing A, Rashid A, Devesa S, Fraumeni JJ. Biliary Tract Cancer. Cancer Epidemiology and Prevention 2006, 787-800. New York: Oxford University Press, Inc, Jr DSJF, Third Edition.
3. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BH, Niwa S, Chen J, et al. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 2007, 97(11):1577-1582. 10.1038/sj.bjc.6604047, 2360257, 18000509.
4. Hsing AW, Gao YT, McGlynn KA, Niwa S, Zhang M, Han TQ, Wang BS, Chen J, Sakoda LC, Shen MC, et al. Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China. Int J Cancer 2007, 120(9):1981-1985. 10.1002/ijc.22375, 17278101.
5. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, Ortiz-Conde BA, Goedert JJ, Fraumeni JF, O'Brien TR, et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 2008, 122(8):1849-1853.
6. Liu E, Sakoda LC, Gao YT, Rashid A, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Fraumeni JF, et al. Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2005, 14(5):1315-1318. 10.1158/1055-9965.EPI-05-0032, 15894693.
7. Vishnoi M, Pandey SN, Choudhuri G, Mittal B. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population. Cancer Genet Cytogenet 2008, 186(2):63-68. 10.1016/j.cancergencyto.2008.05.004, 18940468.
8. Vishnoi M, Pandey SN, Choudhury G, Kumar A, Modi DR, Mittal B. Do TNFA -308 G/A and IL6-174 G/C gene polymorphisms modulate risk of gallbladder cancer in the north Indian population?. Asian Pac J Cancer Prev 2007, 8(4):567-572.
9. Srivastava A, Pandey SN, Choudhuri G, Mittal B. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility. Scand J Immunol 2008, 67(5):516-522. 10.1111/j.1365-3083.2008.02097.x, 18405329.
10. Sakoda LC, Gao YT, Chen BE, Chen J, Rosenberg PS, Rashid A, Deng J, Shen MC, Wang BS, Han TQ, et al. Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 2006, 27(6):1251-1256. 10.1093/carcin/bgi314, 16361272.
11. Hsing AW, Sakoda LC, Rashid A, Andreotti G, Chen J, Wang BS, Shen MC, Chen BE, Rosenberg PS, Zhang M, et al. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res 2008, 68(15):6442-6452. 10.1158/0008-5472.CAN-08-0444, 2860726, 18676870.
12. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260. 10.1146/annurev.immunol.16.1.225, 9597130.
13. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010, 140(6):883-899. 10.1016/j.cell.2010.01.025, 2866629, 20303878.
14. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125(1-2):279-284.
15. Han S, Lee KM, Park SK, Lee JE, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, et al. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res 2010, 34(10):1271-1274. 10.1016/j.leukres.2010.02.001, 20189245.
16. Barry KH, Koutros S, Andreotti G, Sandler DP, Burdette LA, Yeager M, Beane Freeman LE, Lubin JH, Ma X, Zheng T, et al. Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk. Carcinogenesis 2011, 33(2):331-337.
17. Westfall PH, Young SS. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment 1993, New York: John Wiley & Sons.
18. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008, 358(19):2039-2049. 10.1056/NEJMra0706596, 18463380.
19. Castelli J, Wood KA, Youle RJ. The 2-5A system in viral infection and apoptosis. Biomed Pharmacother 1998, 52(9):386-390. 10.1016/S0753-3322(99)80006-7, 9856285.
20. Wiklund F, Jonsson BA, Brookes AJ, Stromqvist L, Adolfsson J, Emanuelsson M, Adami HO, Augustsson-Balter K, Gronberg H. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res 2004, 10(21):7150-7156. 10.1158/1078-0432.CCR-04-0982, 15534086.
21. Madsen BE, Ramos EM, Boulard M, Duda K, Overgaard J, Nordsmark M, Wiuf C, Hansen LL. Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer. PLoS One 2008, 3(6):e2492. 10.1371/journal.pone.0002492, 2424240, 18575592.
22. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 2001, 12(4):375-391. 10.1016/S1359-6101(01)00016-8, 11544106.
23. Andreotti G, Liu E, Gao YT, Safaeian M, Rashid A, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, et al. Medical history and the risk of biliary tract cancers in Shanghai, China: implications for a role of inflammation. Cancer Causes Control 2011, 22(9):1289-1296. 10.1007/s10552-011-9802-z, 21744094.
24. Maurer KJ, Carey MC, Fox JG. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 2009, 136(2):425-440. 10.1053/j.gastro.2008.12.031, 2774219, 19109959.
25. Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie 2001, 386(3):224-229. 10.1007/s004230100220, 23167942.
26. Spirli C, Nathanson MH, Fiorotto R, Duner E, Denson LA, Sanz JM, Di Virgilio F, Okolicsanyi L, Casagrande F, Strazzabosco M. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. Gastroenterology 2001, 121(1):156-169. 10.1053/gast.2001.25516, 11438505.
27. Rotival M, Zeller T, Wild PS, Maouche S, Szymczak S, Schillert A, Castagne R, Deiseroth A, Proust C, Brocheton J, et al. Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans. PLoS Genet 2011, 7(12):e1002367. 10.1371/journal.pgen.1002367, 3228821, 22144904.
28. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011, 43(6):513-518. 10.1038/ng.840, 3325768, 21614091.